Trials / Completed
CompletedNCT03578172
HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients
Randomized, Controlled Trial to Assess the Efficacy of Human Menopausal Gonadotrophin Stimulation and Hormone Replacement Therapy for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe Intrauterine Adhesion Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 186 (actual)
- Sponsor
- Reproductive & Genetic Hospital of CITIC-Xiangya · Academic / Other
- Sex
- Female
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of endometrial preparation using either human menopausal gonadotrophin (HMG) stimulation and hormone replacement therapy (HRT) prior to blastocyst transfer in patients with moderate to severe intrauterine adhesion (IUA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | human menopausal gonadotrophin | experimental group:Women will be given HMG 37.5-150IU daily followed by monitoring of the follicular growth (folliculometry) when serum Estradiol (E2)\<100pg/ml,progesterone (P)\<1ng/ml. Final oocyte maturation will be induced by administration of human chorionic gonadotropin (HCG) when there will be at least one leading follicle ≥20mm in diameter followed by luteal phase support (using progesterone supplements) after 24 hours. |
| DRUG | hormone replacement therapy | Women will be given 17 β-estradiol hemihydrate 2 mg and estrogen gel 5 g daily from day 3 of the cycle then the endometrial thickness will be assessed on day 7 by transvaginal sonography (TVS). If the endometrium is ≥ 9 mm, luteal phase support (using progesterone supplements) will be started but if the endometrium is \< 9 mm, estradiol will be continued until reaching appropriate endometrial thickness and then the luteal phase support will be started. The cycle will be cancelled If the estradiol administration \>60 days. |
Timeline
- Start date
- 2018-07-18
- Primary completion
- 2019-10-20
- Completion
- 2019-11-20
- First posted
- 2018-07-06
- Last updated
- 2022-01-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03578172. Inclusion in this directory is not an endorsement.